Location History:
- Epfenbach D-74925, DE (2000)
- Epfenbach, DE (1999 - 2009)
- Klein Nordende, DE (2016)
Company Filing History:
2 out of 4,455 
12 out of 832,891 Years Active: 1999-2016
Title: Innovations of Klaus Büttner in Dyslipidemia Treatment
Introduction
Klaus Büttner, an accomplished inventor based in Epfenbach, Germany, has made significant contributions to the field of pharmaceuticals with a focus on dyslipidemia. With a portfolio that includes nine patents, his work addresses important health issues through innovative treatments.
Latest Patents
Among Büttner's most notable inventions are his latest patents. One such patent, titled "Multimeric Apoprotein Agonists," provides multimeric apoprotein agonists and pharmaceutical compositions that include these agonists alongside a pharmaceutically acceptable carrier, excipient, or diluent. These compositions are aimed at treating a variety of disorders associated with dyslipidemia. Another significant patent, "Pharmaceutical Compositions of Apolipoprotein A-I Agonists and Their Use to Treat Dyslipidemic Disorders," focuses on peptides and peptide analogues that mimic the properties of human ApoA-I, offering potential treatments for various dyslipidemic conditions.
Career Highlights
Throughout his career, Klaus Büttner has worked with esteemed organizations, most notably Pfizer Corporation, where he expanded his knowledge and expertise in pharmaceutical innovations. His dedication to improving health outcomes through scientific discoveries has solidified his reputation as a notable inventor in his field.
Collaborations
Büttner has collaborated with prominent figures in the industry, including Jean-Louis Henri Dasseux and Renate Sekul. These partnerships have contributed to the development of his innovative solutions, showcasing the importance of teamwork in advancing scientific discoveries and patenting new technologies.
Conclusion
Klaus Büttner’s contributions to the field of pharmaceuticals, particularly in dyslipidemia treatment, underscore the dynamic role of inventors in addressing health challenges. With nine patents to his name, his innovative work continues to pave the way for improved therapeutic options, demonstrating the critical impact of targeted inventions in medicine.